← All diseases Liver, kidneys and digestion

Primary biliary cholangitis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (95)Meta-analysis (34)Treatment guideline (10)Randomized trial (22)Phase 3 Study (15)Systematic review (14)Clinical examination (354)Review article (274)Early study (phase 1 or 2) (18)Case reports (145)Laboratory or animal study (50)Commentary or editorial (39)Retracted publication (2) Studies currently recruiting participants only (32)

Filter

Publications (1516)

• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. (2024/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Newer Diagnostic Virological Markers for Hepatitis B Virus Infection. (2024/07/01) ♡
• Perihilar and Intrahepatic Cholangiocarcinoma after Resection: Clinicopathological Characteristics, Outcomes, and Implications for Addition of Chemoradiotherapy. (2024/07/01) ♡
• Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression. (2024/06/29) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Safety of high-carbohydrate fluid diet 2 h versus overnight fasting before non-emergency endoscopic retrograde cholangiopancreatography: A single-blind, multicenter, randomized controlled trial. (2024/06/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals. (2024/06/20) ♡
• Abdominal Hypoperfusion and Acute Kidney Injury in the Critically Ill Patient with Liver Cirrhosis: A Prospective Cohort Study. (2024/06/18) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort. (2024/06/01) ♡
• Perceived Stigma in Patients with Autoimmune Hepatitis. (2024/06/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Radiographic and endoscopic findings of checkpoint inhibitor cholangitis. (2024/06/01) ♡
• Undifferentiated HepaRG cells show reduced sensitivity to the toxic effects of M8OI through a combination of CYP3A7-mediated oxidation and a reduced reliance on mitochondrial function. (2024/06/01) ♡
• Good long-term outcomes of primary sclerosing cholangitis in childhood. (2024/05/25) ♡
• Frequency of antithyroid antibodies in patients with primary biliary cholangitis. (2024/05/02) ♡
• Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA "Global Study" (EABCIR-Global Study). (2024/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. (2024/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. (2024/05/01) ♡
• Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. (2024/05/01) ♡
• Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. (2024/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm! (2024/05/01) ♡
• Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis. (2024/04/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autosomal Recessive Polycystic Kidney Disease – PKHD1. (2024/04/04) ♡
• A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study. (2024/04/03) ♡
• Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation. (2024/04/01) ♡
• Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. (2024/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. (2024/04/01) ♡
• Efficacy and Safety of Endoscopic Retrograde Cholangiopancreatography in Children of Pancreaticobiliary Maljunction Without Obvious Biliary Dilatation. (2024/04/01) ♡
• Handgrip strength: Best practice for a rapid nutrition screening and risk stratification in male patients with alcoholic liver cirrhosis, a classification and regression tree analysis study. (2024/04/01) ♡
• Galectin-3 in biliary atresia and other pediatric cholestatic liver diseases. (2024/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review. (2024/03/29) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Early hepatic proteomic signatures reveal metabolic changes in high-fat-induced obesity in rats. (2024/03/14) ♡
• Distribution of Splenic Arterial Flow and Segmental Spleen Volume for Partial Splenic Arterial Embolization. (2024/03/09) ♡
• Farnesoid X receptor agonist tropifexor detoxifies ammonia by regulating the glutamine metabolism and urea cycles in cholestatic livers. (2024/03/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of peroxisome proliferator-activated receptors in the regulation of bile acid metabolism. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights. (2024/03/01) ♡
• Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India. (2024/03/01) ♡
• Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis. (2024/02/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Risk factors of primary Sjögren's syndrome combined with osteoporosis. (2024/02/28) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial. (2024/02/27) ♡
• Dietary acid load and cirrhosis-related mortality: a prospective cohort study. (2024/02/14) ♡
• Technical optimization of spatially resolved single-cell transcriptomic datasets to study clinical liver disease. (2024/02/13) ♡
• Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2. (2024/02/10) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation. (2024/02/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Sur (2024/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. (2024/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Imaging of hepato-pancreato-biliary emergencies in patients with cancer. (2024/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT. (2024/02/01) ♡
• Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals. (2024/02/01) ♡
• Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. (2024/01/25) ♡
• Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. (2024/01/24) ♡
• Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L. (2024/01/23) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.